menu
    • menu

    Company profile for Moderna Therapeutics

    NEW Drugs in Dev: 61
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Moderna is a leader in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating mRNA medicines for a wide range of diseases and conditions, in many ...
    Moderna is a leader in the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. With its breakthrough platform, Moderna is creating mRNA medicines for a wide range of diseases and conditions, in many cases by addressing currently undruggable targets or underserved areas of medical need. Moderna is developing its innovative mRNA medicines for infectious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moderna TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    200 Technology Sq, Cambridge, Massachusetts 02139, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.modernatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/moderna-/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moderna CEO Pay Hits $19.9M As Cost Cuts Boost Cash Bonus
    Moderna CEO Pay Hits $19.9M As Cost Cuts Boost Cash Bonus

    17 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/moderna-ceo-stephane-bancel-2025-pay-hits-199m-cash-bonus-more-doubles

    FIERCE PHARMA
    17 Mar 2026
    Share Share
    Roivant Units Reach $2.25B Patent Settlement With Moderna
    Roivant Units Reach $2.25B Patent Settlement With Moderna

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248941/34323/en/Roivant-Announces-Genevant-Sciences-and-Arbutus-Biopharma-s-2-25-Billion-Global-Settlement-With-Moderna.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    EU Backs Approval for Moderna's combined COVID and flu Vaccines
    EU Backs Approval for Moderna's combined COVID and flu Vaccines

    28 Feb 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-gets-eu-regulator-nod-combined-covid-flu-vaccine-2026-02-27/

    REUTERS
    28 Feb 2026
    Share Share
    FDA Backs Moderna's mRNA-1010, Revolutionizing Seasonal Flu Shots
    FDA Backs Moderna's mRNA-1010, Revolutionizing Seasonal Flu Shots

    24 Feb 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/fda-reversal-on-modernas-mrna-1010-can-transform-the-seasonal-influenza-vaccines-market-globaldata/

    EXPRESSPHARMA
    24 Feb 2026
    Share Share
    BioNTech Sues Moderna For Patent Infringement Over COVID Shot
    BioNTech Sues Moderna For Patent Infringement Over COVID Shot

    20 Feb 2026

    // REUTERS

    https://www.reuters.com/world/biontech-sues-moderna-patent-infringement-over-covid-19-shots-2026-02-19/

    REUTERS
    20 Feb 2026
    Share Share
    FDA Accepts Filing For Moderna Flu Vaccine After Swift Rethink
    FDA Accepts Filing For Moderna Flu Vaccine After Swift Rethink

    19 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fda-accepts-filing-moderna-flu-vaccine-after-swift-u-turn

    FIERCE BIOTECH
    19 Feb 2026
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search